On June 10, 2014, FDA hosted a public meeting on Patient-Focused Drug Development for Inborn Errors of Metabolism. FDA was interested in obtaining patient perspectives on the impact of Inborn Errors of Metabolism on daily life and patient views on treatment approaches. For more information, visit https://go.usa.gov/x69cX.
source
Public Meeting on Patient Focused Drug Development for Inborn Errors of Metabolism Part 2
